MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Author MStranslate

MStranslate

Jonathan Kipnis

Lymphatic System in the Brain: Prof Jonathan Kipnis

MStranslate
July 7, 2015
Research
In early June, media outlets across the world featured groundbreaking research undertaken by the Kipnis Lab at the University of Virginia. Published in Nature, this study showed the presence of a lymphatic...
Teisha Rose

Google Hangout featuring Teisha Rose

MStranslate
July 2, 2015
Google Hangouts
On June 25, 2015, we held a Google Hangout with special guest, Teisha Rose, author of the book “Life Interrupted”. Teisha’s book is a very personal insight into her multiple sclerosis journey,...

Announcing Brand New Monday Meet-ups!

MStranslate
June 19, 2015
Events, Google Hangouts
We are pleased to announce that Brett will now be hosting private Google Hangouts every Monday night between 7pm and 8pm. This will be an opportunity to come in and discuss all things related to multiple...
Stem Cell Therapy

Stem Cell Therapy in Multiple Sclerosis

MStranslate
June 18, 2015
Stem Cells, Treatments
A/Prof Helmut Butzkueven from the Melbourne Brain Centre speaks with us to help clear up the confusion surrounding the use of Stem Cell Therapy in multiple sclerosis. He explains how stem cells are currently...

Compound Reduces Neurodegeneration in Mouse Model of MS

MStranslate
June 2, 2015
Research
Researchers from Virginia Commonwealth University and the University of Illinois at Chicago have identified a compound that is able to reduce neurodegeneration in a mouse model of multiple sclerosis. The...

Vitamin D – All About the Timing?

MStranslate
May 19, 2015
Lifestyle, Research, Vitamin D
There has been a long-held belief that low-levels of Vitamin D may increase the risk of developing multiple sclerosis. This has been supported by the worldwide distribution of MS, where lower rates are...

Vitamin B7 – Potential New Therapy for Progressive MS

MStranslate
May 13, 2015
Research, Treatments
Progressive MS is (finally) starting to be a major focus of MS research - both in trying to understand what triggers the shift from the relapsing-remitting form and in the development of effective treatments...

Nanoparticles Used to Deliver Myelin Repair Molecule

MStranslate
May 7, 2015
Research, Treatments
In recent years, a large focus of MS research around the world has been promoting remyelination - that is, the process of repairing damaged nerves. In a recent study published in Biomaterials Science, a team...

PwMS Victoria Annual Conference 2015

MStranslate
May 5, 2015
Conferences, Presentations
A big thank you to the team at People with Multiple Sclerosis - Victoria Incorporated for inviting us to present at their annual conference last Saturday (May 2)!  We could not have asked for a warmer and...

Prolactin: A Novel Therapy for Multiple Sclerosis?

MStranslate
April 23, 2015
Research
By Brett Drummond Prolactin, the hormone responsible for milk production in women, has been previously shown to have the ability to remyelinate damaged nerves.  Therefore, it's potential for use as a...
  1. 25
  2. 26
  3. 27
  4. 28
  5. 29
  6. 30
  7. 31

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.